4.1 Cost savings associated with the use of the CardioQ-ODM in patients undergoing major or high-risk surgery are largely derived from a reduction in the length of critical care and in-hospital stay. Additional savings will result from a reduction in post-operative complications.
4.2 A report from the NHS Technology Adoption Centre considered the potential economic impact of the widespread adoption of the CardioQ-ODM across five surgical specialties in the NHS. This report is published at www.technologyadoptionhub.nhs.uk/doppler-guided-intraoperative-fluid-management/executive-summary.htmlht
4.3 The Committee was advised that the use of the CardioQ-ODM in a peri-operative setting or critical care environment requires a trained clinician or nurse to re-adjust the device and interpret the readings.
4.4 The Committee was informed that the CardioQ-ODM has been available to the NHS for a number of years but, although used routinely in some hospitals, could be adopted more widely. The Committee was advised that current barriers to wider adoption include financial, training and motivational issues.